CVS Health Corporation

One CVS Drive

Woonsocket, RI 02895

July 1, 2015

VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention:	Jeffrey P. Riedler
Re:	CVS Health Corporation
	Registration Statement on Form S-3
	(Registration File No. 333-205156)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration by the Securities and Exchange Commission (the “Commission”) of the effective date of the Registration Statement on Form S-3 (Registration No. 333-205156) (the “Registration Statement”) of CVS Health Corporation (the “Corporation”). We respectfully request that the Registration Statement become effective as of 1:00 p.m., Washington, DC time, on July 2, 2015, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Shearman & Sterling LLP, by calling Stephen T. Giove at (212) 848-7325.

The Company acknowledges the following:

• should the Commission or the staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

• the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

1

• the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your assistance in this matter.

Very truly yours,

CVS Health Corporation

/s/ Colleen M. McIntosh

Colleen M. McIntosh

Senior Vice President, Corporate Secretary & Assistant General Counsel

cc:	Daniel Greenspan, Securities and Exchange Commission
	Christina De Rosa, Securities and Exchange Commission
	David M. Denton, CVS Health Corporation
	Thomas M. Moriarty, CVS Health Corporation
	Stephen T. Giove, Shearman & Sterling LLP

2